CD47 and neoplasm: Camouflaged by CM, PEG2000‐SiNcTI‐Ph/CpG‐ZIF‐8@CM could evade immune surveillance by activating the CD47/SIRPα pathway to target CT26 tumor cells mediated by PD‐1/PD‐L1 interaction.